Pharmaron funding history / development milestones

IPO,

2019.11.28,

IPO上市,创业板

2019.01.28,深交所

战略投资,2.8亿美元

Note: collected from public online reports, for reference only.

People who follow Pharmaron also follow

Pharmaron Competitors (Similar Companies)

制药/药业 医药 医药中间体 中间体
“Research, development, and production of anti-tumor and surgical medic”
新药研发 生命科学 SMO CRO
医药 生物医药 医疗科技 医药科技
“To develop high-quality biologics that are accessible and affordable f”
“Technological innovation and commercial application of pharmaceutical ”
“Professional services for the entire clinical trial process of drug pr”
新药研发 CRO 动物实验 气质联用
临床研究 药物研发 新药研发 转化医学
“A leading open-access capability and technology platform company for p”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Continuously innovating to bring patients medicines that significantly”
“One of the leading enterprises in the pharmaceutical industry”
“Large-scale pharmaceutical distribution enterprise”
“Making drugs and cures accessible to all”